title: Genomic instability and tumorigenic induction in immortalized human bronchial epithelial cells by heavy ions.
abstract: Carcinogenesis is postulated to be a progressive multistage process characterized by an increase in genomic instability and clonal selection with each mutational event endowing a selective growth advantage. Genomic instability as manifested by the amplification of specific gene fragments is common among tumor and transformed cells. In the present study, immortalized human bronchial (BEP2D) cells were irradiated with graded doses of either 1GeV/nucleon 56Fe ions or 150 keV/micrometer alpha particles. Transformed cells developed through a series of successive steps before becoming tumorigenic in nude mice. Tumorigenic cells showed neither ras mutations nor deletion in the p16 tumor suppressor gene. In contrast, they harbored mutations in the p53 gene and over-expressed cyclin D1. Genomic instability among transformed cells at various stage of the carcinogenic process was examined based on frequencies of PALA resistance. Incidence of genomic instability was highest among established tumor cell lines relative to transformed, non-tumorigenic and control cell lines. Treatment of BEP2D cells with a 4 mM dose of the aminothiol WR-1065 significantly reduced their neoplastic transforming response to 56Fe particles. This model provides an opportunity to study the cellular and molecular mechanisms involved in malignant transformation of human epithelial cells by heavy ions.
authors.affiliation: Center for Radiological Research, Columbia University, New York 10032, USA.
authors.forename: T K
authors.initials: TK
authors.lastname: Hei
authors.forename: C Q
authors.initials: CQ
authors.lastname: Piao
authors.forename: L J
authors.initials: LJ
authors.lastname: Wu
authors.forename: J C
authors.initials: JC
authors.lastname: Willey
authors.forename: E J
authors.initials: EJ
authors.lastname: Hall
mesh_terms: D000512:Alpha Particles; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D001980:Bronchi / Q000166:cytology / Q000473:pathology / Q000528:radiation effects; D002459:Cell Fusion; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic; D004847:Epithelial Cells / Q000473:pathology / Q000528:radiation effects; D005784:Gene Amplification; D016147:Genes, Tumor Suppressor; D020450:Heavy Ions; D006801:Humans; D007501:Iron; D018499:Linear Energy Transfer; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology; D008624:Mercaptoethylamines / Q000494:pharmacology; D051379:Mice; D008819:Mice, Nude; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011837:Radiation-Protective Agents / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D008624:Mercaptoethylamines; D011837:Radiation-Protective Agents; C020174:N-(2-mercaptoethyl)-1,3-diaminopropane; D001224:Aspartic Acid; C013195:sparfosic acid; D007501:Iron; D010746:Phosphonoacetic Acid